Is this a red flag or white?

Attachments

  • CRBP_Put_2020-09-01-Tu_EOD.png
    CRBP_Put_2020-09-01-Tu_EOD.png
    70.6 KB · Views: 4
Last edited:
Broker requires 100% margin on that stock for naked options which actually makes my returns lower. Instead of getting $1.25 for putting up $600 with 1 naked put, I can get 3 credit spreads for $.75 each collecting $2.25 while still only putting up the same $600 because the margin is only $200 per credit spread.

So that's why I do it that way. So I make 80% more money.

Hope that clears it up.

Very nice, I stand corrected.
 
Bid/ask on the $11 is $3/$5.10

Bid/ask on the $12.50 is $4.50/$5.80

You can't go by last price because some of those trades may have executed several minutes or even hours apart.
Yes, that's true, but one can use the midpoint of Bid and Ask as an orientation,
and the yahoo data in the screenshot says/said 2.45/5.90 and 5.10/7.00 .
Getting 6.05 and 4.175 as midpoints --> https://www.optioncreator.com/st7n8ni
Still a little arbitrage of 38c present :)
 
Last edited:
One thing with CRBP I don't understand: their press release from Aug 5, 2020
https://ir.corbuspharma.com/press-r...maceuticals-completes-enrollment-in-determine says this
"The Company expects to report topline results from this study in the fourth quarter of 2021."
That's more than a year till Q4 2021.
So then why does the stock and its options have such a high volatility like above 300% ?
Never seen such a thing. Usually the IV begins to rise only about a few months before the FDA decision.
 
Yes, that's true, but one can use the midpoint of Bid and Ask as an orientation,
and the yahoo data in the screenshot says/said 2.45/5.90 and 5.10/7.00 .
Getting 6.05 and 4.175 as midpoints --> https://www.optioncreator.com/st7n8ni
Still a little arbitrage of 38c present :)

The spreads on many stocks get wide at close so you can't go by that. On live trading I'm seeing the midpoint at $.90 on those contracts. But if you think you can get in it, go for it. You only have to put up $150 to try.
 
One thing with CRBP I don't understand: their press release from Aug 5, 2020
https://ir.corbuspharma.com/press-r...maceuticals-completes-enrollment-in-determine says this
"The Company expects to report topline results from this study in the fourth quarter of 2021."
That's more than a year till Q4 2021.
So then why does the stock and its options have such a high volatility like above 300% ?
Never seen such a thing. Usually the IV begins to rise only about a few months before the FDA decision.

I'm sure I've read everything about Corbus. I think you're confusing 2 different drug trials (and results). They have 1 drug lebasarum (or something sounding) that it's near the phase 3 completion on a treatment for systemic sclerosis and in phase 2 for another trial of a dug for cystic fibrosis in mid/late 2021.

Also another good write up was done yesterday:
https://www.marketbeat.com/originals/corbus-pharamceuticals-nasdaq-give-a-bold-buy-sigmal/

Personally, I just want the stock to gyrate back and forth though I do feel (highly likely) it will appreciate in the near term causing my option play not to be as enticing in the future as it is currently.
 
Fucking BS analysts in this world. Will Lose $3k in each account now. Going back to just day trading and index future trading - no fucking manipulations there!!
 
Back
Top